Cargando…
Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis
RATIONALE: While one of the basic axioms of pharmacology postulates that there is a relationship between the concentration and effects of a drug, the value of measuring blood levels is questioned by many clinicians. This is due to the often-missing validation of therapeutic reference ranges. OBJECTI...
Autores principales: | Hart, Xenia M., Hiemke, Christoph, Eichentopf, Luzie, Lense, Xenija M., Clement, Hans Willi, Conca, Andreas, Faltraco, Frank, Florio, Vincenzo, Grüner, Jessica, Havemann-Reinecke, Ursula, Molden, Espen, Paulzen, Michael, Schoretsanitis, Georgios, Riemer, Thomas G., Gründer, Gerhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584998/ https://www.ncbi.nlm.nih.gov/pubmed/36195732 http://dx.doi.org/10.1007/s00213-022-06233-2 |
Ejemplares similares
-
Therapeutic Reference Ranges for Psychotropic Drugs: A Protocol for Systematic Reviews
por: Hart, Xenia M., et al.
Publicado: (2021) -
Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy
por: Eichentopf, Luzie, et al.
Publicado: (2022) -
Low Escitalopram Concentrations in Patients with Depression predict
Treatment Failure: A Naturalistic Retrospective Study
por: Hart, Xenia M., et al.
Publicado: (2023) -
Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorder
por: Hart, X. M., et al.
Publicado: (2022) -
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
por: Vierke, Christopher, et al.
Publicado: (2020)